Cellular & Molecular Immunology

Welcome to Cellular & Molecular Immunology

Current issue

New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein
Junzhi Wang

Research Highlight Open Access 26 Nov 2020
COVID-19 and flu: conserved or specific immune signature?
Christophe Paget
François Trottein

Research Highlight Open Access 11 Jan 2021
The interplay between dendritic cells and CD8 T lymphocytes is a crucial component of SARS-CoV-2 immunity
Jonas Buttenschön
Jochen Mattner

Research Highlight Open Access 08 Jan 2021
The roles of microglia in viral encephalitis: from sensome to therapeutic targeting
Chintan Chhatbar
Marco Prinz

Review Article Open Access 12 Jan 2021
The aryl hydrocarbon receptor and the gut–brain axis
Andreia Barroso
João Vitor Mahler
Francisco J. Quintana

Review Article Open Access 06 Jan 2021
New insights into the cell- and tissue-specificity of glucocorticoid actions
Linda Quatrini
Sophie Ugolini

Review Article 31 Aug 2020

Volume 18 Issue 2

Contents

View all issues

Featured

Clinical development of CAR T cell therapy in China: 2020 update
Jianshu Wei
Yelei Guo
Weidong Han

Review Article Open Access 30 Sept 2020
Themis regulates metabolic signaling and effector functions in CD4⁺ T cells by controlling NFAT nuclear translocation
Mukul Prasad
Joanna Brzostek
Nicholas R. J. Gascoigne

Article Open Access 11 Nov 2020
Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods
Berislav Bošnjak
Saskia Catherina Stein
Reinhold Förster

Article Open Access 02 Nov 2020
Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease
Andrea Kristina Horst
Kingsley Gideon Kumashie
Gisa Tiegs

Review Article Open Access 27 Oct 2020

Cellular & Molecular Immunology is a Transformative Journal; authors can publish using the traditional publishing route OR Open Access.

Our Open Access option complies with funder and institutional requirements.

Browse articles

IL-6R blockade by chikusetsusaponin IVa butyl ester inhibits Th17 cell differentiation and ameliorates collagen-induced arthritis
Jie Yang
Yuanyuan Ling
Peng Cao

Correspondence 26 Feb 2021
Downregulated miR-451a as a feature of the plasma cfRNA landscape reveals regulatory networks of IL-6/IL-6R-associated cytokine storms in COVID-19 patients
Penghui Yang
Yingze Zhao
Hai-Xi Sun

Correspondence 26 Feb 2021
SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation
Wenjing Wang
Zhuo Zhou
Jianwei Wang

Article Open Access 26 Feb 2021
Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
Jie Hu
Pai Peng
Ai-long Huang

Correspondence 25 Feb 2021
Ferritin nanoparticle-based SARS-CoV-2 RBD vaccine induces a persistent antibody response and long-term memory in mice
Wenjun Wang
Baoying Huang
Mingzhao Zhu

Correspondence 12 Feb 2021
Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques
Rong Li
Xiancai Ma
Hui Zhang

Correspondence 12 Feb 2021
Bridging the gap—Immune cells that can repair nerves
Helen M. McGettrick

Research Highlight Open Access 12 Feb 2021
SEMA3A-mediated crosstalk between prostate cancer cells and tumor-associated macrophages promotes androgen deprivation therapy resistance
Fei Liu
Chao Wang
Shancheng Ren

Correspondence 08 Feb 2021
A new predictive biomarker enables more accurate PD-1 blockade therapy
Kuojun Zhang
Sheng Jiang

Research Highlight 08 Feb 2021

Trending - Altmetric

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.

Quick links